Background: Triphala is an indigenous medical product used for a variety of diseases. This study was conducted to determine the effect of Triphala on antibiotic properties of gentamicin and oxacillin against multi-drug resistant organisms. Methods: The checkerboard method was used to determine the synergy of Triphala with gentamicin and oxacillin against multi-drug resistant (MDR) Gram negative bacilli and methicillin-resistant Staphylococcus aureus (MRSA) using 2,3,5-triphenyltetrazolium chloride (TTC) assay. Fractional inhibitory concentration (FIC) index was calculated.
Background
Triphala is an indigenous medicinal product used in diseases in nose and skin wounds, tumours, cough and upper respiratory diseases, peptic ulcer, mouth ulcers, anemia, abdominal pain, obesity, liver diseases and toxic conditions [1] [2] [3] . It is composed of dried pericarp of the fruits of three plants, Terminalia chebula Retz. The biological activity of Triphala has been studied in some detail, including in animal experiments. Triphala is known to have antimicrobial activity, anti-viral activity, anti-oxidant activity including the ability to scavenge free radicals, anti-inflammatory activity, anti-pyretic activity, wound healing properties, anti-mutagenic and anti-carcinogenic activity as well as hypoglycaemic effects [4] [5] [6] . Extracts of Triphala and its individual plants have demonstrated varying degree of activity against a range of Gram negative and Gram positive bacteria [7] [8] [9] [10] .
Furthermore, Triphala has also shown antibacterial activity against Enterococcus faecalis in biofilms formed on dental substrates [11] . A mouthwash prepared from Triphala has been effective in reducing dental plaque formation [12] .
Triphala has been incorporated in collagen sponges to reduce wound infection and facilitate healing [13] .
Antimicrobial resistance (AMR) is a major issue faced by health care professionals globally. In addition to the identification of novel antibiotics, enhancing the activity of existing antibiotics by combining with novel compounds can also be considered as a strategy to overcome the problem of AMR.
Gentamicin is an aminoglycoside with activity against both Gram negative and positive organisms. Gentamicin is used routinely in combination with other classes of antibiotics in the treatment of different types of bacterial infections. Oxacillin is an indicator drug used to assess sensitivity of Staphylococcus aureus to β-lactam antibiotics, the main group of antibiotics used to treat staphylococcal infections unless the isolate is a methicillin-resistant Staphylococcus aureus (MRSA). Although synergistic activity of component plants of Triphala with some antibiotics have been studied [14] , the synergy between Triphala and gentamicin and oxacillin has not been studied previously to the best of our knowledge. The current study was therefore conducted with the objective of characterizing the antimicrobial activity of Triphala against multi-drug resistant (MDR) organisms and to evaluate synergistic activity with gentamicin and oxacillin against appropriate organisms.
Methodology

Preparation of solid extract of Triphala
Specimens of the three constituent plants of Triphala were identified and confirmed by the National Herbarium, Department of National Botanic Gardens, Peradeniya, Sri Lanka and deposited in the National Herbarium with the following tag numbers; Terminalia chebula -522, Terminalia bellirica -816 and Phyllanthus emblica -428 (letter No. 6/01/H/03, dated 2015.11.26 and 2016.01.07).
The dried fruits of T. chebula, T. bellirica and P. emblica bought from a Medicinal shop in Kandy, Sri Lanka were washed with sterile distilled water and crushed to remove the seeds. The pericarp of the three fruits were weighed separately (40 g each), mixed together, to prepare Triphala. An aqueous extract of Triphala was prepared by boiling the Triphala (120 g) in distilled water (400 ml) to 1/8th the initial volume, meeting the conditions of traditional drug preparation. The aqueous extract was freeze-dried and the solid residue was stored in a deep freezer (− 20°C); the solid residue was used for preparing a dilution series of Triphala as described below.
Microorganisms
Synergistic activity was tested using 12 MDR pathogens: Serratia liquefaciens, Serratia marcescens, Serratia odorifera biogroup 1, Proteus spp., three isolates of Klebsiella pneumoniae, Enterobacter cloacae, two isolates of Pseudomonas aeruginosa, two isolates of Acinetobacter spp. and five isolates of Methicillin Resistant Staphylococcus aureus (MRSA) obtained from the Department of Microbiology, Faculty of Medicine, University of Peradeniya and Teaching Hospital, Peradeniya. The organisms were stored at − 80°C (Thermo Scientific freezer) until testing. Antibiotic susceptibility testing was performed for a selected group of drugs using the Clinical and Laboratory Standards Institute [15] recommendations, prior to testing for MIC.
Preparation of the dilution series of Triphala and antibiotics
The dilution series 5000-4.88 μg/ml of Triphala was prepared using a stock solution of Triphala (10,000 μg/ ml) by using double dilution method. Dilution series ranging from 5000 to 9.78 μg/ml was used to test synergistic activity of Triphala and gentamicin against the MDR Gram negatives and a dilution series ranging from 2500 to 4.88 μg/ml was used to test for synergy between Triphala and oxacillin against MRSA.
The dilution series of gentamicin used for synergy testing ranged from 64 to 2 μg/ml. The dilution series of oxacillin used for synergy testing ranged from 32 to 0.5 μg/ml.
Synergistic activity
Synergistic activity was tested using 2,3,5-triphenyltetrazolium chloride (TTC) assay, using sterile 96 well flat bottomed plates as described previously [16] . Results were read using a colour change.
Calculation of mean fractional inhibitory concentration (FIC) index
The value of the mean fractional inhibitory concentration (FIC) index as a predictor of synergy was calculated using the recorded MICs [17] .
The interaction was defined as synergistic if the FIC index was < 1, additive if the FIC index was 1 and antagonistic if the FIC index was > 1 [16, 18] .
Results
All isolates tested were confirmed to be MDR organisms being resistant to three or more classes of antibiotics (Table 1) .
MIC values when tested alone and in combination
When tested alone, the MIC values of gentamicin for the Gram negative isolates ranged from 8 to > 64 μg/ml (Table 2 and Additional file 1: Table S1 ). All enterobacteriaceae isolates had MICs within the resistant range to The MIC values of oxacillin for the MRSA isolates ranged from 4 to > 16 μg/ml with all MICs being equal to or higher than the resistance cut-off level. The MIC level with the addition of Triphala ranged from 0.25 to 4 μg/ml. Four out of the five isolates demonstrated a drop in the MIC to the sensitive range (Table 3 and Additional file 1: Table S2 ).
The FIC indices were calculated for gentamicin-Triphala and oxacillin-Triphala combinations (Table 4) . Eleven of the twelve gentamicin-Triphala interactions and all oxacillin-Triphala interactions were synergistic while one gentamicin-Triphala interaction, for a Pseudomonas aeruginosa isolate was additive in nature. None of them were antagonistic.
Discussion
In the current study, we demonstrated that Triphala interacts in a synergistic manner with gentamicin against the selected MDR Gram negative bacilli and with oxacillin against MRSA. Aminoglycosides including gentamicin act by interfering with bacterial protein synthesis. Gentamicin has been used widely in combination with other β-lactam antibiotics [19] . Non-lethal damage by theβ-lactam antibiotics to the cell wall of bacteria is considered to facilitate the entry of the aminoglycoside antibiotic to the bacterial cell, enhancing its killing ability [20] . Aminoglycoside resistance, including resistance to gentamicin occurs through enzymatic deactivation of the S Sensitive, R Resistant drug, active efflux of the drug or cell wall changes leading to reduced uptake of the drug and decreased binding of the drug to the 16S ribosome due to mutations or methylation [19] . Both ethanolic and aqueous extracts of Triphala contain phenolics, flavonoids and carotenoids [21] . Antibacterial activity of Triphala has been shown to correlate to its phenolic content [22] . Phenolic compounds are known to disrupt the cell membranes of bacteria [23] . Therefore, the mechanism of synergy between gentamicin and Triphala may be similar to that between gentamicin andβ-lactams. Oxacillin acts by interfering with cell wall synthesis. The main mechanism of resistance to all β-lactams in MRSA is the presence of PBP2a that has a lower affinity to this group of drugs [24] . Synergy between phenolic compounds and oxacillin against MRSA, similar to our findings, has been documented previously [25, 26] .
The chemical structures of active phenolic compounds determine their antibacterial activity [23] . Therefore, it is important that the active phytochemicals of Triphala be identified and their structures elucidated in furthering this study.
While synergism or additive activity was noted across all antimicrobial-plant compounds tested in the study, not all gentamicin MIC drops resulted in achieving clinical sensitive breakpoints. Furthermore, no consistency has been observed in the reversion of gentamicin MIC to sensitive levels across the organisms tested. Presence of varying mechanisms of resistance among the test isolates may have contributed to this. As the mechanisms of resistance for the test isolates were not established, we are unable to further validate this claim.
While there was a drop in the MIC of Triphala against all organisms tested when used in combination with the antibiotics, the values remained relatively high (original MIC values not shown). However, the reported MIC values for Triphala and its constitutive plant products when tested alone has ranges similar to that obtained in our study [22, 23] . Similar levels have been reported for other plant products as well [27, 28] .
Aminoglycoside use had increased in the recent past for the treatment of infections caused by MDR organisms as the rate of emergence of resistance to aminoglycosides has been low. However, the reason for discontinuation of the aminoglycoside in many instances is nephrotoxicity [29] . Interestingly, Triphala has renal protective effects both in animal studies [30] and limited clinical studies [31] , presumably due to its antioxidant properties. In vitro and invivo studies of Triphala and gentamicin together to explore the possible benefits are warranted in future.
Conclusion
In conclusion, Triphala demonstrated synergistic activity with gentamicin against selected MDR Gram negative bacilli and with oxacillin against MRSA, warranting 
